Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
暂无分享,去创建一个
K. Neville | P. Adamson | M. Bernstein | T. Horton | M. Krailo | S. Berg | S. Blaney | J. Ginsberg | B. Kitchen